Developing novel therapeutic approaches to treat chronic kidney disease [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Progression of chronic kidney disease (CKD) to endstage is characterised by inflammation and fibrosis. No current treatment effectively halts CKD progression. We are using protective immune cells to treat CKD and have invented a genetically-engineered immune cell which uses damaging inflammatory signals to switch them into protective cells which reverse inflammation and fibrosis where they occur, to prevent progression of CKD and other diseases, such as those of heart, lung and liver.

Funding Amount $2,173,545

Funding Scheme Investigator Grants

Chief Investigator Prof David Harris

Notes Leadership 3